Abstract |
Burning mouth syndrome is a complex pathology for which there is very little information about the etiology and pathogenesis. This lack of knowledge leaves patients with suboptimal treatments. This article discusses the existing scientific evidence about this disease. Since topical oral use of clonazepam have been shown to be effective and safe to treat some patients suffering with burning mouth syndrome, formulations including clonazepam are included with this article. Compounding topical preparations of clonazepam offers opportunities for compounding pharmacists to be more involved in improving the quality of life of burning mouth syndrome patients.
|
Authors | Eyal Zur |
Journal | International journal of pharmaceutical compounding
(Int J Pharm Compd)
2012 May-Jun
Vol. 16
Issue 3
Pg. 196-205
ISSN: 1092-4221 [Print] United States |
PMID | 23050296
(Publication Type: Journal Article, Review)
|
Chemical References |
- Paroxetine
- Clonazepam
- Thioctic Acid
|
Topics |
- Acupuncture Therapy
- Burning Mouth Syndrome
(diagnosis, epidemiology, etiology, therapy)
- Clonazepam
(therapeutic use)
- Humans
- Paroxetine
(therapeutic use)
- Prevalence
- Thioctic Acid
(therapeutic use)
|